Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia

Paul M. McNeill, I. H. Kerridge, D. A. Henry, Barrie J. Stokes, Suzanne R. Hill, D. Newby, G. J. Macdonald, Richard O. Day, David J. Maguire, K. M. Henderson

Research output: Contribution to journalArticleResearchpeer-review

27 Citations (Scopus)

Abstract

Background: This study investigated the 'gift-relationship' between pharmaceutical companies and doctors. Methods: The study was based on a survey questionnaire of 823 medical specialists from across Australia. The aim of this study was to investigate gifts offered to medical specialists in Australia by pharmaceutical companies, financial support actively sought by medical specialists for activities other than research and to consider what is ethically appropriate. Results: A high percentage of specialists received offers of food (96%), items for the office (94%), personal gifts (51%) and journals or textbooks (50%). Most specialists were invited to product launches, symposia or educational events (75-84%) and 52% received offers of travel to conferences. A high proportion of offers were accepted (66-79%) except invitations to product launches (49%), sponsored symposia (53%) and offers of travel that included partners (27%). Fifteen per cent of specialists requested financial support from pharmaceutical companies for activities and items, including conferences, travel, educational activities, salaries and donations to specific funds. The study outlined guidelines on gifts from pharmaceutical companies and differing standards applying to gifts and grants for travel. We found that, although most gifts and requests for support complied with professional and pharmaceutical industry guidelines, some - including personal gifts, tickets to sporting events, entertainment and travel expenses for specialists' partners - did not. Conclusion: To ensure that physicians' judgements are free from real or perceived influence from industry and to maintain public trust, we support a shift towards more conservative standards on gifts and support for travel evident in recent guidelines.

Original languageEnglish
Pages (from-to)571-578
Number of pages8
JournalInternal Medicine Journal
Volume36
Issue number9
DOIs
Publication statusPublished - Sep 2006
Externally publishedYes

Fingerprint

Gift Giving
Pharmaceutical Preparations
Financial Support
Guidelines
Textbooks
Organized Financing
Salaries and Fringe Benefits
Drug Industry
Financial Management
Industry
Physicians
Education
Food

Cite this

McNeill, Paul M. ; Kerridge, I. H. ; Henry, D. A. ; Stokes, Barrie J. ; Hill, Suzanne R. ; Newby, D. ; Macdonald, G. J. ; Day, Richard O. ; Maguire, David J. ; Henderson, K. M. / Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. In: Internal Medicine Journal. 2006 ; Vol. 36, No. 9. pp. 571-578.
@article{02caa4fad88f4bc9a76bbecb930d1881,
title = "Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia",
abstract = "Background: This study investigated the 'gift-relationship' between pharmaceutical companies and doctors. Methods: The study was based on a survey questionnaire of 823 medical specialists from across Australia. The aim of this study was to investigate gifts offered to medical specialists in Australia by pharmaceutical companies, financial support actively sought by medical specialists for activities other than research and to consider what is ethically appropriate. Results: A high percentage of specialists received offers of food (96{\%}), items for the office (94{\%}), personal gifts (51{\%}) and journals or textbooks (50{\%}). Most specialists were invited to product launches, symposia or educational events (75-84{\%}) and 52{\%} received offers of travel to conferences. A high proportion of offers were accepted (66-79{\%}) except invitations to product launches (49{\%}), sponsored symposia (53{\%}) and offers of travel that included partners (27{\%}). Fifteen per cent of specialists requested financial support from pharmaceutical companies for activities and items, including conferences, travel, educational activities, salaries and donations to specific funds. The study outlined guidelines on gifts from pharmaceutical companies and differing standards applying to gifts and grants for travel. We found that, although most gifts and requests for support complied with professional and pharmaceutical industry guidelines, some - including personal gifts, tickets to sporting events, entertainment and travel expenses for specialists' partners - did not. Conclusion: To ensure that physicians' judgements are free from real or perceived influence from industry and to maintain public trust, we support a shift towards more conservative standards on gifts and support for travel evident in recent guidelines.",
author = "McNeill, {Paul M.} and Kerridge, {I. H.} and Henry, {D. A.} and Stokes, {Barrie J.} and Hill, {Suzanne R.} and D. Newby and Macdonald, {G. J.} and Day, {Richard O.} and Maguire, {David J.} and Henderson, {K. M.}",
year = "2006",
month = "9",
doi = "10.1111/j.1445-5994.2006.01151.x",
language = "English",
volume = "36",
pages = "571--578",
journal = "Australian and New Zealand Journal of Medicine",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "9",

}

McNeill, PM, Kerridge, IH, Henry, DA, Stokes, BJ, Hill, SR, Newby, D, Macdonald, GJ, Day, RO, Maguire, DJ & Henderson, KM 2006, 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia' Internal Medicine Journal, vol. 36, no. 9, pp. 571-578. https://doi.org/10.1111/j.1445-5994.2006.01151.x

Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. / McNeill, Paul M.; Kerridge, I. H.; Henry, D. A.; Stokes, Barrie J.; Hill, Suzanne R.; Newby, D.; Macdonald, G. J.; Day, Richard O.; Maguire, David J.; Henderson, K. M.

In: Internal Medicine Journal, Vol. 36, No. 9, 09.2006, p. 571-578.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia

AU - McNeill, Paul M.

AU - Kerridge, I. H.

AU - Henry, D. A.

AU - Stokes, Barrie J.

AU - Hill, Suzanne R.

AU - Newby, D.

AU - Macdonald, G. J.

AU - Day, Richard O.

AU - Maguire, David J.

AU - Henderson, K. M.

PY - 2006/9

Y1 - 2006/9

N2 - Background: This study investigated the 'gift-relationship' between pharmaceutical companies and doctors. Methods: The study was based on a survey questionnaire of 823 medical specialists from across Australia. The aim of this study was to investigate gifts offered to medical specialists in Australia by pharmaceutical companies, financial support actively sought by medical specialists for activities other than research and to consider what is ethically appropriate. Results: A high percentage of specialists received offers of food (96%), items for the office (94%), personal gifts (51%) and journals or textbooks (50%). Most specialists were invited to product launches, symposia or educational events (75-84%) and 52% received offers of travel to conferences. A high proportion of offers were accepted (66-79%) except invitations to product launches (49%), sponsored symposia (53%) and offers of travel that included partners (27%). Fifteen per cent of specialists requested financial support from pharmaceutical companies for activities and items, including conferences, travel, educational activities, salaries and donations to specific funds. The study outlined guidelines on gifts from pharmaceutical companies and differing standards applying to gifts and grants for travel. We found that, although most gifts and requests for support complied with professional and pharmaceutical industry guidelines, some - including personal gifts, tickets to sporting events, entertainment and travel expenses for specialists' partners - did not. Conclusion: To ensure that physicians' judgements are free from real or perceived influence from industry and to maintain public trust, we support a shift towards more conservative standards on gifts and support for travel evident in recent guidelines.

AB - Background: This study investigated the 'gift-relationship' between pharmaceutical companies and doctors. Methods: The study was based on a survey questionnaire of 823 medical specialists from across Australia. The aim of this study was to investigate gifts offered to medical specialists in Australia by pharmaceutical companies, financial support actively sought by medical specialists for activities other than research and to consider what is ethically appropriate. Results: A high percentage of specialists received offers of food (96%), items for the office (94%), personal gifts (51%) and journals or textbooks (50%). Most specialists were invited to product launches, symposia or educational events (75-84%) and 52% received offers of travel to conferences. A high proportion of offers were accepted (66-79%) except invitations to product launches (49%), sponsored symposia (53%) and offers of travel that included partners (27%). Fifteen per cent of specialists requested financial support from pharmaceutical companies for activities and items, including conferences, travel, educational activities, salaries and donations to specific funds. The study outlined guidelines on gifts from pharmaceutical companies and differing standards applying to gifts and grants for travel. We found that, although most gifts and requests for support complied with professional and pharmaceutical industry guidelines, some - including personal gifts, tickets to sporting events, entertainment and travel expenses for specialists' partners - did not. Conclusion: To ensure that physicians' judgements are free from real or perceived influence from industry and to maintain public trust, we support a shift towards more conservative standards on gifts and support for travel evident in recent guidelines.

UR - http://www.scopus.com/inward/record.url?scp=33746786455&partnerID=8YFLogxK

U2 - 10.1111/j.1445-5994.2006.01151.x

DO - 10.1111/j.1445-5994.2006.01151.x

M3 - Article

VL - 36

SP - 571

EP - 578

JO - Australian and New Zealand Journal of Medicine

JF - Australian and New Zealand Journal of Medicine

SN - 1444-0903

IS - 9

ER -